There is increasing evidence of peripheral and central immune system cross connectivity contributing to acceleration of a proinflammatory state in ALS [245]
its safety and tolerability have not been fully clarified, and breakthroughs are still needed in production process optimization and raw material supply
is on the Advisory Board of Amylin, Boehringer Ingelheim, Merck and Novo Nordisk and has received research grant support from Amylin, Bristol-Myers-Squibb, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk and AstraZeneca
Activating c-Met in healthy people, which is what Dihexa is designed to do, runs in the opposite direction
- PubMed - NCBI." [Online]